r
mdash
dr
dourmashkin
colleagu
nov
p
report
seen
pleomorph
coronaviruslik
particl
specimen
human
faec
postul
may
deriv
intestin
yeastlik
organ
suggest
blastocysti
believ
protozoon
describ
coronaviruslik
particl
human
faec
quit
differ
cellular
materi
illdefin
commonli
present
human
faecal
materi
date
one
strain
coronaviruslik
particl
shown
replic
cell
organ
cultur
system
produc
ultrastructur
chang
indistinguish
produc
bovin
coronaviru
similar
intestin
organ
cultur
system
section
particl
seen
insid
cell
typic
coronavirus
conclud
particl
enter
coronavirus
common
featur
enter
coronavirus
pleomorph
find
unusu
envelop
rna
virus
especi
adapt
vitro
cultur
evid
viral
natur
particl
must
consid
find
dourmashkin
et
al
conclud
particl
saw
probabl
virus
conclus
base
interpret
structur
relationship
obtain
section
deposit
ultracentrifug
crude
faecal
suspens
believ
interpret
find
pilot
experi
difficult
also
inappropri
question
pose
sir
mdash
dr
berkowitz
colleagu
oct
p
conclud
oral
contracept
increas
risk
proiifer
trophoblast
sequela
taken
evacu
hydatidiform
mole
gonadotrophin
valu
fallen
normal
clear
conclus
drawn
total
patient
select
random
file
statist
signific
would
seem
highli
question
relev
data
might
also
question
ground
group
report
elsewher
give
cytotox
drug
patient
judg
risk
malign
sequela
even
uteru
evacu
prophylact
therapi
affect
issu
two
way
first
ensur
high
proport
mole
patient
receiv
potenti
mutagen
cytotox
agent
childbear
period
wherea
other
think
desir
avoid
exposur
secondli
render
seri
unsuit
comparison
seri
patient
given
prophylact
therapi
analysi
consecut
regist
case
hydatidiform
mole
registri
royal
colleg
obstetrician
gynaecologist
suggest
take
oral
contracept
gonadotrophin
remiss
achiev
increas
risk
invas
mole
choriocarcinoma
almost
compar
take
oestrogen
data
conclus
sinc
patient
randomis
pill
pill
group
would
seem
better
basi
mole
followup
polici
new
england
data
sir
dr
gorchein
juli
p
comment
letterl
perhap
point
clearli
knew
induct
acid
synthetas
dose
relat
phenomenon
moreov
gener
exist
larg
speci
variat
therapeut
toxic
effect
chemic
substanc
addit
interspeci
differ
exist
drug
metabol
pharmacolog
respons
especi
liposolubl
drug
point
consid
extrapol
find
rat
man
nevertheless
feel
strongli
drug
evok
posit
respons
rat
model
potenti
harm
hereditari
porphyria
avoid
take
except
gorchein
suggest
safeti
new
drug
hereditari
porphyria
evalu
clinic
trial
would
irrespons
subject
popul
risk
potenti
harm
agent
great
deal
success
evidenc
remark
decreas
number
acut
educ
affect
subject
medic
attend
dire
consequ
exposur
potenti
danger
drug
furthermor
good
correl
exist
clinic
find
rat
model
respect
danger
porphyrogen
drug
sir
dr
hawkin
colleagu
studi
thyroid
microsom
antibodi
tma
nov
p
face
dilemma
bedevil
much
epidemiolog
research
problem
studi
individu
subject
subject
tma
subclin
hypothyroid
premyxoedema
accord
hawkin
colleagu
criterion
rais
basal
thyroid
stimul
hormon
tsh
level
experi
patient
premyxoedema
normal
basal
tsh
exagger
respons
thyrotrophinreleas
hormon
trh
